title: Formulation and process design for a solid dosage form containing a spray-dried amorphous dispersion of ibipinabant.
abstract: Amorphous forms of poorly soluble drugs are more frequently being incorporated into solid dispersions for administration and extensive research has led to a reasonable understanding of how these dispersions, although still kinetically unstable, improve stability relative to the pure amorphous form. There remains however a paucity of literature describing the effects on such solid dispersions of subsequent processing into solid dosage forms such as tablets. This paper addresses this area by looking at the effects of the addition of common excipients and different manufacturing routes on the stability of a spray-dried dispersion (SDD) of the cannabinoid CB-1 antagonist, ibipinabant. A marked difference in physical stability of tablets was seen with the different fillers with microcrystalline cellulose (MCC) giving the best stability profile. It was found that minimising the number of compression steps led to improved formulation stability with a direct compression process giving the best results. Increased levels of crystallinity were seen in coated tablets most likely due to the exposure of the amorphous matrix to moisture and heat during the coating process. DSIMS analysis of the SDD particles indicated increased levels of polymer on the surface.
authors.affiliation: Drug Product Science and Technology, Bristol-Myers Squibb, Moreton, Wirral, UK. michael.leane@bms.com
authors.forename: Michael M
authors.initials: MM
authors.lastname: Leane
authors.forename: Wayne
authors.initials: W
authors.lastname: Sinclair
authors.forename: Feng
authors.initials: F
authors.lastname: Qian
authors.forename: Raja
authors.initials: R
authors.lastname: Haddadin
authors.forename: Alan
authors.initials: A
authors.lastname: Brown
authors.forename: Mike
authors.initials: M
authors.lastname: Tobyn
authors.forename: Andrew B
authors.initials: AB
authors.lastname: Dennis
mesh_terms: D000578:Amidines / Q000008:administration & dosage / Q000737:chemistry*; D002482:Cellulose / Q000008:administration & dosage / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical / Q000379:methods; D004355:Drug Stability; D005079:Excipients / Q000008:administration & dosage / Q000737:chemistry; D011108:Polymers / Q000008:administration & dosage / Q000737:chemistry*; D011720:Pyrazoles / Q000008:administration & dosage / Q000737:chemistry*; D012995:Solubility; D013607:Tablets / Q000008:administration & dosage / Q000737:chemistry
chemical_list: D000578:Amidines; D005079:Excipients; D011108:Polymers; D011720:Pyrazoles; D013607:Tablets; D002482:Cellulose; C569626:ibipinabant; C109691:microcrystalline cellulose